Sen. John Boozman Sells UnitedHealth Group Incorporated (NYSE:UNH) Stock

Senator John Boozman (R-Arkansas) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on July 09th, the Senator disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on June 11th.

Senator John Boozman also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Micron Technology (NASDAQ:MU) on 6/11/2025.
• Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 6/11/2025.
• Purchased $1,001 – $15,000 in shares of Invesco Short Term Treasury ETF (NYSEARCA:TBLL) on 6/11/2025.
• Sold $1,001 – $15,000 in shares of Fortune Brands Innovations (NYSE:FBIN) on 5/30/2025.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 5/30/2025.
• Purchased $1,001 – $15,000 in shares of RTX (NYSE:RTX) on 5/30/2025.
• Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOGL) on 5/20/2025.
• Sold $1,001 – $15,000 in shares of NRG Energy (NYSE:NRG) on 5/20/2025.
• Sold $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 5/20/2025.
• Sold $1,001 – $15,000 in shares of DTE Energy (NYSE:DTE) on 5/20/2025.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $280.69 on Monday. The company has a market capitalization of $254.62 billion, a PE ratio of 11.75, a PEG ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock’s fifty day simple moving average is $301.58 and its 200 day simple moving average is $424.22.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.15%. The ex-dividend date was Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Baird R W cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. TD Securities reiterated a “hold” rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Mizuho lowered their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Finally, Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $392.29.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently made changes to their positions in UNH. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $28,000. Bayforest Capital Ltd raised its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its position in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the firm’s stock in a transaction on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director owned 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by insiders.

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas’ U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman’s academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.